447 / 1778
Results
• 3 Y PFS 74.4% Vs 69%
(p=0.029)
• Median PFS- HR 0.68
• Statistically significant
improvement in median PFS
Conclusion: Gemcitabine + cisplatin CRT
followed by Brachy & adjuvant gem/cis
CT improved survival outcomes with
increased but clinically manageable
toxicity compared to standard Rx